Cardiac stem cell therapy research in China

Article Contents

Article Navigation > Journal of Geriatric Cardiology > 2006 > 3(3): 184-186

Junbo GE. Cardiac stem cell therapy research in China. J Geriatr Cardiol 2006; 3(3): 184-186.

Citation:

Junbo GE. Cardiac stem cell therapy research in China. J Geriatr Cardiol 2006; 3(3): 184-186.

Junbo GE. Cardiac stem cell therapy research in China. J Geriatr Cardiol 2006; 3(3): 184-186.

Citation:

Junbo GE. Cardiac stem cell therapy research in China. J Geriatr Cardiol 2006; 3(3): 184-186.

Center of Stem Cell and Tissue Engineering, Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Abstract

For more than two decades, the morbidity and mortality of coronary artery disease (CAD) has been increasing rapidly in China. Despite tremendous advances in treatment strate-gies of CAD, heart failure after acute myocardial infarction (AMI) continues to be one of the greatest medical chal-lenges throughout the world. In 1994, Soonpaa and col-leagues first reported the possibility of cardiomyocytes implantation and suggested that intracardiac cell grafting might provide a useful approach for myocardial repair.1 Cell implantation has become a novel therapeutic option for is-chemic cardiac injury and heart failure.